NCT05544799

Brief Summary

An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
69mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jan 2021Dec 2031

Study Start

First participant enrolled

January 3, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 14, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 16, 2022

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2031

Last Updated

February 2, 2026

Status Verified

January 1, 2026

Enrollment Period

7 years

First QC Date

September 14, 2022

Last Update Submit

January 29, 2026

Conditions

Near Death Experience

Outcome Measures

Primary Outcomes (1)

  • Incidence of near death experience (NDE)

    Incidence of case with NDE scale ≥7 point

    5 years

Interventions

No interventionOTHER

No intervension

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hematologic cancers who are in admission.

You may qualify if:

  • Adult patients (≥19yrs) who are in admission in the Hematology ward of Seoul National University Hospital, and one of the following conditions.
  • recovered after cardiopulomary resuscitation
  • recovered after mechanical ventilator
  • recovered after ICU care
  • recovered after emergent operation
  • recovered after Shock, coma, altered mentality
  • Other medical conditions approaching death

You may not qualify if:

  • Those who do not agree to participate this study
  • Those who can not be interviewed due to insufficient recovery from critical medical problems

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Saliva for DNA extraction

MeSH Terms

Conditions

Death

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Dong-Yeop Shin, MD, PhD

    Department of Internal Medicine, Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dong-Yeop Shin, MD, PhD

CONTACT

+82220727209stephano.dyshin@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 14, 2022

First Posted

September 16, 2022

Study Start

January 3, 2021

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2031

Last Updated

February 2, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)